Expanding treatment eligibility for chronic hepatitis B: Balancing benefits, limitations, and healthcare access: Correspondence to editorial on “Antiviral therapy for chronic hepatitis B with mildly elevated aminotransferase: A rollover study from the TOR Yao-Chun Hsu, Chi-Yi Chen, Jaw-Town Lin Clinical and Molecular Hepatology.2025; 31(2): e169. CrossRef